CTNNB1 and glioblastoma: Combined targeting of WNT signaling and autophagy may therefore be beneficial in glioblastoma with high WNT signaling, but may also suggest that tumors with low WNT-CTNNB1 with high autophagy-SQSTM1 expression will be sensitive to autophagy inhibition [57].